COMPOSITION CONTAINING SOLID DISPERSION OF BAZEDOXIFENE ACETATE Russian patent published in 2010 - IPC A61K31/404 A61K31/55 A61P5/24 A61P9/10 A61K9/14 A61P15/00 A61P19/10 

Abstract RU 2400227 C2

FIELD: medicine.

SUBSTANCE: invention refers to pharmacology. A solid pharmaceutical dispersion contains bazedoxifene acetate dispersed in a dispersant, and said dispersant contains polyvinylpyrrolidone, poloxamer, polyethylene glycol, or a mixture or copolymer of said substances. The invention refers also to the compositions containing said dispersion, to methods for making the solid pharmaceutical dispersion containing bazedoxifene acetate and the composition and a dosage form containing the solid pharmaceutical dispersion containing bazedoxifene acetate for treatment of a disease or a syndrome associated with oestrogen hunger or excess, a disease or a disorder associated with proliferation or pathological development of endometrial tissues, cholesterol reduction, bone loss inhibition and breast cancer treatment. Besides the invention covers the methods of treating mammals suffering a disease or a syndrome associated with oestrogen hunger or excess, or a disease or a disorder associated with proliferation or pathological development of endometrial tissues, or cholesterol reduction in a mammal, bone loss inhibition in a mammal or breast cancer treatment in a mammal, treatment of one or more vasomotor disorders in postmenopausal women, including the introduction of therapeutically effective amounts of the solid pharmaceutical dispersion, and also to the application of the solid pharmaceutical dispersion containing bazedoxifene acetate for preparing a drug for treatment of a disease or a syndrome associated with oestrogen hunger or excess, a disorder associated with proliferation or pathological development of endometrial tissues, cholesterol reduction, bone loss inhibition and breast cancer treatment.

EFFECT: invention provides higher clinical effectiveness.

38 cl, 6 tbl, 2 dwg, 4 ex

Similar patents RU2400227C2

Title Year Author Number
BAZEDOXIFENE TREATMENT SCHEDULE 2003
  • Komm Barri S.
  • Ehrmer Dzhejms K.
  • Kollinz Mark A.
  • Ferron Zheral'Din M.
  • Bud Pol
  • D'Julin Vendi A.
  • Dzhenkins Sajmon N.
RU2355397C2
PHARMACEUTICAL COMPOSITIONS CONTAINING CONJUGATED ESTROGENS AND BAZEDOXIFENE 2006
  • Chatlapalli Ramarao S.
  • Nagi Arvinder
  • Van Pel'T Lorens
RU2395286C2
SOLID DISPERSIONS, CONTAINING KINASE INHIBITORS 2011
  • Miller Dzhonatan
  • Gokkhale Radzhiv
  • Shmitt Ehrik A.
  • Gao I.
  • Lafunten Dzhastin
  • Dias Llojd
RU2566716C2
SOLID DISPERSION 2012
  • Fraj Devid Shenk
  • Lindemann Kristofer M.
  • Prej Majkl
  • Blum Kori Dzhej
  • Krejg Kristofer Donovan
  • Dyuboz Devon Brevar
  • Gotshi Dzhef
  • Smiti Den
RU2648448C2
COMPOSITIONS CONTAINING BAZEDOXIFENE ACETATE 2006
  • Shakh Said M.
  • Diorio Kristofer R.
  • Ehrnsperger Ehrik S.
  • Ali Kadum A.
RU2417084C2
SOLID DISPERSIONS 2016
  • Chen, Chzhenmin
  • Chen, Syaomin
  • Khalloran, Kevin
RU2694832C2
(-)-CIS-6(S)-PHENYL-5(R)-[4-(2-PYRROLIDINE-1-YLETHOXY)PHENYL]- -5,6,7,8-TETRAHYDRONAPHTHALINE-2-OL D-TARTRATE, METHOD OF ITS SYNTHESIS, METHOD OF PROPHYLAXIS OF STATES INFLUENCING WITH TO EFFECT OF ESTROGEN AGONISTS, PHARMACEUTICAL COMPOSITION 1996
  • Charl'Z K. Chiu
  • Morgan Mel'Tts
RU2162465C2
TREATMENT OF BRAIN CANCER 2013
  • Li Patris A.
  • Vinski Shannon L.
  • Koch Kevin
RU2672575C2
NAPHTHYL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES 1996
  • Alan Dehvid Pal'Kovich
RU2167849C2
TRANSDERMAL DELIVERY OF LAZOPHOXIPHEN 2001
  • Fikstehd Dehvid
  • Kvuan Danij
RU2328276C2

RU 2 400 227 C2

Authors

Shakh Sied M.

Ali Kadum A.

Ofslager Kristian L.

Favzi Makhdi B.

Dates

2010-09-27Published

2005-04-07Filed